Stock-Based Compensation - Summary of consolidated statements of operations (Details) - 2019 Plan - USD ($) $ in Thousands |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|
Stock Option Disclosures | |||
Total stock-based compensation expense | $ 15,591 | $ 10,919 | $ 8,470 |
Costs of goods sold | |||
Stock Option Disclosures | |||
Total stock-based compensation expense | 215 | 157 | 167 |
Sales and marketing | |||
Stock Option Disclosures | |||
Total stock-based compensation expense | 2,341 | 2,905 | 2,585 |
Research and development | |||
Stock Option Disclosures | |||
Total stock-based compensation expense | 2,640 | 1,923 | 1,376 |
General and administrative | |||
Stock Option Disclosures | |||
Total stock-based compensation expense | $ 10,395 | $ 5,934 | $ 4,341 |
X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|